Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

2020 Proceedings of the National Academy of Sciences 1,134 citations

Abstract

Significance Since SARS-CoV-2 emerged in China, it has spread rapidly around the world. Effective vaccines and therapeutics for SARS-CoV-2−induced disease (coronavirus disease 2019;COVID-19) are urgently needed. We found that SARS-CoV-2 isolates replicate efficiently in the lungs of Syrian hamsters and cause severe pathological lesions in the lungs of these animals similar to commonly reported imaging features of COVID-19 patients with pneumonia. SARS-CoV-2−infected hamsters mounted neutralizing antibody responses and were protected against rechallenge with SARS-CoV-2. Moreover, passive transfer of convalescent serum to naïve hamsters inhibited virus replication in their lungs. Syrian hamsters are a useful small animal model for the evaluation of vaccines, immunotherapies, and antiviral drugs.

Keywords

MesocricetusVirologyHamsterSyrian hamstersSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PneumoniaCoronavirus disease 2019 (COVID-19)Neutralizing antibodyCoronavirusDiseaseAntibodyVirusViral replicationMedicineBiologyImmunology2019-20 coronavirus outbreakInfectious disease (medical specialty)PathologyOutbreakInternal medicine

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
article
Volume
117
Issue
28
Pages
16587-16595
Citations
1134
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1134
OpenAlex

Cite This

Masaki Imai, Kiyoko Iwatsuki‐Horimoto, Masato Hatta et al. (2020). Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proceedings of the National Academy of Sciences , 117 (28) , 16587-16595. https://doi.org/10.1073/pnas.2009799117

Identifiers

DOI
10.1073/pnas.2009799117